Feb 13, 2025 8:30am EST Sonnet BioTherapeutics Appoints Stephen McAndrew, Ph.D. as Chief Business Officer
Feb 13, 2025 8:00am EST Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings Update